Renée Komorowski

2.7k total citations · 1 hit paper
24 papers, 1.2k citations indexed

About

Renée Komorowski is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Renée Komorowski has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Molecular Biology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Renée Komorowski's work include Diabetes Treatment and Management (8 papers), Pancreatic function and diabetes (6 papers) and Xenotransplantation and immune response (4 papers). Renée Komorowski is often cited by papers focused on Diabetes Treatment and Management (8 papers), Pancreatic function and diabetes (6 papers) and Xenotransplantation and immune response (4 papers). Renée Komorowski collaborates with scholars based in United States, Switzerland and Canada. Renée Komorowski's co-authors include Murielle M. Véniant, Glenn Sivits, Katherine A. Winters, David J. Lloyd, Clarence Hale, Joan Helmering, Shanaka Stanislaus, Carolyn F. Moyer, Todd Hager and Wei Fan and has published in prestigious journals such as PLoS ONE, Cell Metabolism and Endocrinology.

In The Last Decade

Renée Komorowski

24 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

2024 115 citations Murielle M. Véniant, Shu-Chen Lu et al. Nature Metabolism profile →

Peers

Renée Komorowski

EDM

PHYSI

SURGE

RHEUM

Akira Matsutani Japan

Jean‐Valéry Turatsinze Belgium

Søren M. Echwald Denmark

Snehal Desai United States

Meena Asmar Denmark

Latif Rachdi France

Sanda Ljubicic Switzerland

B. Obermaier–Kusser Germany

Roberto De Pirro Italy

B Ermel Germany

Akira Matsutani Japan

Renée Komorowski

428 ×0.8

210 ×0.5

EDM

116 ×0.3

PHYSI

452 ×1.5

SURGE

31 ×0.2

RHEUM

Citations per year, relative to Renée Komorowski Renée Komorowski (= 1×) peers Akira Matsutani

Countries citing papers authored by Renée Komorowski

Since Specialization

Citations

This map shows the geographic impact of Renée Komorowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renée Komorowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renée Komorowski more than expected).

Fields of papers citing papers by Renée Komorowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renée Komorowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renée Komorowski. The network helps show where Renée Komorowski may publish in the future.

Co-authorship network of co-authors of Renée Komorowski

This figure shows the co-authorship network connecting the top 25 collaborators of Renée Komorowski. A scholar is included among the top collaborators of Renée Komorowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renée Komorowski. Renée Komorowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Clarissa M., Elizabeth A. Killion, Rola Hammoud, et al.. (2025). GIPR-Ab/GLP-1 peptide–antibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice. Nature Metabolism. 7(6). 1266–1281. 11 indexed citations

Véniant, Murielle M., Shu-Chen Lu, Larissa Atangan, et al.. (2024). A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings. Nature Metabolism. 6(2). 290–303. 115 indexed citations breakdown →

Lu, Shu-Chen, Michelle Chen, Larissa Atangan, et al.. (2021). GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys. Cell Reports Medicine. 2(5). 100263–100263. 71 indexed citations

Xiong, Yumei, Kenneth W. Walker, Xiaoshan Min, et al.. (2017). Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys. Science Translational Medicine. 9(412). 174 indexed citations

Véniant, Murielle M., Glenn Sivits, Joan Helmering, et al.. (2015). Pharmacologic Effects of FGF21 Are Independent of the “Browning” of White Adipose Tissue. Cell Metabolism. 21(5). 731–738. 172 indexed citations

Smith, Richard J., Amy Duguay, Alice Bakker, et al.. (2013). FGF21 Can Be Mimicked In Vitro and In Vivo by a Novel Anti-FGFR1c/β-Klotho Bispecific Protein. PLoS ONE. 8(4). e61432–e61432. 46 indexed citations

Lu, Shu-Chen, Larissa Atangan, Ki Won Kim, et al.. (2012). An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice. Journal of Lipid Research. 53(4). 643–652. 16 indexed citations

Véniant, Murielle M., Renée Komorowski, Ping Chen, et al.. (2012). Long-Acting FGF21 Has Enhanced Efficacy in Diet-Induced Obese Mice and in Obese Rhesus Monkeys. Endocrinology. 153(9). 4192–4203. 124 indexed citations

Gu, Wei, David J. Lloyd, Renée Komorowski, et al.. (2011). Pharmacological Targeting of Glucagon and Glucagon-Like Peptide 1 Receptors Has Different Effects on Energy State and Glucose Homeostasis in Diet-Induced Obese Mice. Journal of Pharmacology and Experimental Therapeutics. 338(1). 70–81. 28 indexed citations

10.

Yuan, Chester, David Chow, Michelle Chen, et al.. (2011). Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters. 2(11). 824–827. 18 indexed citations

11.

Gu, Wei, Katherine A. Winters, Alykhan Motani, et al.. (2010). Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor. American Journal of Physiology-Endocrinology and Metabolism. 299(4). E624–E632. 45 indexed citations

12.

Yan, Hai, Wei Gu, Jie Yang, et al.. (2009). Fully Human Monoclonal Antibodies Antagonizing the Glucagon Receptor Improve Glucose Homeostasis in Mice and Monkeys. Journal of Pharmacology and Experimental Therapeutics. 329(1). 102–111. 110 indexed citations

13.

Lau, Yvonne, Peiming Ma, Leonid Gibiansky, et al.. (2009). Pharmacokinetic and Pharmacodynamic Modeling of a Monoclonal Antibody Antagonist of Glucagon Receptor in Male ob/ob Mice. The AAPS Journal. 11(4). 700–709. 11 indexed citations

14.

Gu, Wei, Hai Yan, Katherine A. Winters, et al.. (2009). Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible α-Cell Hyperplasia and Hyperglucagonemia. Journal of Pharmacology and Experimental Therapeutics. 331(3). 871–881. 84 indexed citations

15.

Véniant, Murielle M., et al.. (2008). Time of the day for 11β‐HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice. Diabetes Obesity and Metabolism. 11(2). 109–117. 22 indexed citations

16.

Hari, Parameswaran, et al.. (2008). Delayed enhancement on cardiac MRI in a patient with multiple myeloma without amyloidosis. British Journal of Radiology. 81(971). e272–e275. 6 indexed citations

17.

Jean, David J. St., Chester Yuan, Eric A. Bercot, et al.. (2007). 2-(S)-Phenethylaminothiazolones as Potent, Orally Efficacious Inhibitors of 11β-Hydroxysteriod Dehydrogenase Type 1. Journal of Medicinal Chemistry. 50(3). 429–432. 40 indexed citations

18.

Franco, José, et al.. (1994). Cytomegalovirus infection causing pseudomembranous colitis.. PubMed. 89(12). 2246–8. 18 indexed citations

19.

O’Hair, Daniel, Allan M. Roza, Galen M. Pieper, et al.. (1992). Platelet activating factor antagonist RP-59227 reduces vascular injury in discordant cardiac xenograft rejection.. PubMed. 24(2). 702–3. 4 indexed citations

20.

Kinney, T R, et al.. (1991). Reversibility of cardiac xenograft rejection in primates.. PubMed. 10(4). 567–76. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact